<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36334706</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>83</EndPage><MedlinePgn>75-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2022.11.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(22)00185-7</ELocationID><Abstract><AbstractText>TANK-binding kinase 1 (TBK1) is an essential protein kinase for activation of interferon regulatory factor 3 (IRF3) and induction of the type I interferons (IFN-I). Although the biochemical regulation of TBK1 activation has been studied, little is known about how enterovirus 71 (EV71) employs the deubiquitinases (DUBs) to regulate TBK1 activation for viral immune evasion. Here, we found that EV71 infection upregulated the expression of ubiquitin-specific protease 24 (USP24). Further studies revealed that USP24 physically interacted with TBK1, and can reduce K63-linked polyubiquitination of TBK1. Knockdown of USP24 upregulated TBK1 K63-linked polyubiquitination, promoted the phosphorylation and nuclear translocation of IRF3, and in turn improved IFN-I production during EV71 infection. As a consequence, USP24 knockdown dramatically inhibited EV71 infection. This study revealed USP24 as a novel regulator of TBK1 activation, which promotes the understanding of immune evasion mechanisms of EV71 and could provide a potential strategy for treatment of EV71 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zang</LastName><ForeName>Lichao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hubei Hospital of Integrated Chinese and Western Medicine, Wuhan, 430015, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yukang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, 215123, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jinhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yumin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, 215123, China; Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou, 215123, China. Electronic address: huizheng@suda.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213003, China. Electronic address: swf67113@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D064570">Ubiquitin-Specific Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064570" MajorTopicYN="N">Ubiquitin-Specific Proteases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">Innate immunity</Keyword><Keyword MajorTopicYN="N">TANK-binding kinase 1 (TBK1)</Keyword><Keyword MajorTopicYN="N">Type I interferons (IFN-I)</Keyword><Keyword MajorTopicYN="N">Ubiquitin-specific protease 24 (USP24)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36334706</ArticleId><ArticleId IdType="pmc">PMC10006192</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2022.11.001</ArticleId><ArticleId IdType="pii">S1995-820X(22)00185-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basit A.W., Cho M.-G., Kim E.-Y., Kwon D., Kang S.-J., Lee J.H. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels. Exp. Mol. Med. 2020;52:643&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7210884</ArticleId><ArticleId IdType="pubmed">32284536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedekovics T., Hussain S., Zhang Y., Ali A., Jeon Y.J., Galardy P.J. USP24 is a cancer-associated ubiquitin hydrolase, novel tumor suppressor, and chromosome instability gene deleted in neuroblastoma. Cancer Res. 2021;81:1321&#x2013;1331. USP24 loss causes chromosome instability and cancer.</Citation><ArticleIdList><ArticleId IdType="pubmed">33355202</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasius A.L., Beutler B. Intracellular Toll-like receptors. Immunity. 2010;32:305&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">20346772</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M.C., Mosaheb M.M., Mohme M., Mckay Z.P., Holl E.K., Kastan J.P., Yang Y., Beasley G.M., Hwang E.S., Ashley D.M., Bigner D.D., Nair S.K., Gromeier M. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling. Nature Comm. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994570</ArticleId><ArticleId IdType="pubmed">33767151</ArticleId></ArticleIdList></Reference><Reference><Citation>Calistri A., Munegato D., Carli I., Parolin C., Pal&#xf9; G. The ubiquitin-conjugating system: multiple roles in viral replication and infection. Cells. 2014;3:386&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4092849</ArticleId><ArticleId IdType="pubmed">24805990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chathuranga K., Weerawardhana A., Dodantenna N., Lee J.-S. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing. Exp. Mol. Med. 2021;53:1647&#x2013;1668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592830</ArticleId><ArticleId IdType="pubmed">34782737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouri E., Wang M., Hillen M.R., Angiolilli C., Rossato M. Implication of miR-126 and miR-139-5p in plasmacytoid dendritic cell dysregulation in systemic sclerosis. J.&#xa0;Clin. Med. 2021;10:491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866506</ArticleId><ArticleId IdType="pubmed">33573268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., Mcminn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J.&#xa0;Gen. Virol. 2008;89:1622&#x2013;1632.</Citation><ArticleIdList><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong H., Du N., Yang Y., Song L., Zhang W., Tien P. Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax. J.&#xa0;Virol. 2016;90:9862&#x2013;9877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068536</ArticleId><ArticleId IdType="pubmed">27558414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J., Song Y., Li Y., Zhu Q., Peng T., Qin Y., Wang H.Y. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res. 2014;24:400&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3975496</ArticleId><ArticleId IdType="pubmed">24366338</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng M., Tam J.W., Wang L., Liang K., Li S., Zhang L., Guo H., Luo X., Zhang Y., Petrucelli A.S., Davis B.K., Conti B.J., June Brickey W., Ko C.-C., Lei Y.L., Sun S.-C., Ting J.P.-Y. TRAF3IP3 negatively regulates cytosolic RNA induced anti-viral signaling by promoting TBK1 K48 ubiquitination. Nature Comm. 2020;11:2193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198545</ArticleId><ArticleId IdType="pubmed">32366851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y., Mao R., Yang Y., Liu S., Yang J. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J.&#xa0;Exp. Med. 2014;211:313&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920558</ArticleId><ArticleId IdType="pubmed">24493797</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng N., Zhou Z., Li Y., Zhao L., Xue Z., Lu R., Jia K. Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res. 2017;237:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28506791</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Li R., Tan Z., Shi J., Fu Y., Song Y., Zhu M., Zhang L., Huang J. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis. Mol. Immunol. 2020;121:195&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">32298923</ArticleId></ArticleIdList></Reference><Reference><Citation>He H., Yi L., Zhang B., Yan B., Xiao M., Ren J., Zi D., Zhu L., Zhong Z.-H., Zhao X., Jin X., Xiong W. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway. Int. J. Biol. Sci. 2021;17:2417&#x2013;2429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315027</ArticleId><ArticleId IdType="pubmed">34326684</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Ma S., Tian Y., Wei C., Zhu Y., Li F., Zhang P., Wang P., Zhang Y., Zhong H. ERR&#x3b1; negatively regulates type I interferon induction by inhibiting TBK1-IRF3 interaction. PLoS Pathog. 2017;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5476288</ArticleId><ArticleId IdType="pubmed">28591144</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell. 2011;146:448&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179916</ArticleId><ArticleId IdType="pubmed">21782231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.C., Wang H.C., Shih S.R., Teng I.F., Tseng C.P. Synergistic inhibition of enterovirus 71 replication by interferon and Rupintrivir. J.&#xa0;Infect. Dis. 2011;203:1784.</Citation><ArticleIdList><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie C., Huie J., Andrea M.N., Paul B., Rivi&#xe8;re J., Zhiyong L., Roger C., Danyel L., Wesley T., Jeremy M. Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis. J.&#xa0;Exp. Med. 2021;218</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8570298</ArticleId><ArticleId IdType="pubmed">34726731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing L., Yi L., Zhao J., Yu J., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J.&#xa0;Virol. 2012;86:3767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. Innate immune recognition of viral infection. Uirusu. 2006;56:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17038806</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W.X., Yan B., Yeo H., Tan E.L., Lee J.J., Ng J.K.W., Chow V.T., Alonso S. A&#xa0;non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J.&#xa0;Virol. 2012;86:2121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoshnood B., Ullgren A., Laffita-Mesa J., &#xd6;ijerstedt L., Patra K., Nennesmo I., Graff C. TBK1 haploinsufficiency results in changes in the K63-ubiquitination profiles in brain and fibroblasts from affected and presymptomatic mutation carriers. J.&#xa0;Neurol. 2021;1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120096</ArticleId><ArticleId IdType="pubmed">34800171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J.&#xa0;Biomed. Sci. 2020;27:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Liu X., Ma Y., Sun Z., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J.&#xa0;Virol. 2010;84:8051&#x2013;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Sun Z., Liu X., Jin Q., He B., Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J.&#xa0;Virol. 2011;85:8811&#x2013;8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J.&#xa0;Virol. 2013;87:1690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.A., Chen Z.B., Lv T.G., Han Z.L., Liu P.P. Impact of endothelial nitric oxide synthase gene polymorphism on severity of enterovirus 71-infection in Chinese children. Clin. Biochem. 2013;46:1842&#x2013;1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">24140479</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Schrodi S., Rowland C., Tacey K., Catanese J., Grupe A. Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum. Mutat. 2010;27:1017&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pubmed">16917932</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.-L. Type I interferons protect mice against enterovirus 71 infection. J.&#xa0;Gen. Virol. 2005;86:3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J.&#xa0;Virol. 2012;86:3767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira S.A., Li Y.J., Noureddine M.A., Z&#xfc;chner S., Qin X., Pericak-Vance M.A., Vance J.M. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am. J. Hum. Genet. 2005;77:252&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1224528</ArticleId><ArticleId IdType="pubmed">15986317</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian F., Langereis M.A., Lork M., Mai N., Kuppeveld F.J.M.V. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J.&#xa0;Virol. 2014;88:3369&#x2013;3378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M., Khanbabaei H., Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev. Med. Virol. 2018;29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Ding T., Zuo Z., Xu Z., Deng J., Wei Z. Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front. Immunol. 2020;11:1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267026</ArticleId><ArticleId IdType="pubmed">32536927</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Stollar V., Li M.L. Host factors in enterovirus 71 replication. J.&#xa0;Virol. 2011;85:9658&#x2013;9666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Thayer J.A., Awad O., Hegdekar N., Sarkar C., Tesfay H., Burt C., Zeng X., Feldman R.A., Lipinski M.M. The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability. Autophagy. 2020;16:140&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6984603</ArticleId><ArticleId IdType="pubmed">30957634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.-M., Wang M.-L., Zhao J. Crosstalk between autophagy and type I interferon responses in innate antiviral immunity. Viruses. 2019;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6409909</ArticleId><ArticleId IdType="pubmed">30717138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Zhao Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ji L., Yuan X., Jin Y., Xing Z. Differential regulation of TLR signaling on the induction of antiviral interferons in human intestinal epithelial cells infected with enterovirus 71. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805281</ArticleId><ArticleId IdType="pubmed">27007979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Lei X., Xia X., Yang C., Lu W. Reciprocal regulation between enterovirus 71 and the NLRP3 inflammasome. Cell Rep. 2015;12:42&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">26119741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Liu S., Wang J., Wu Y., Cai F., Song W. Transcriptional regulation of human USP24 gene expression by NF-kappa B. J.&#xa0;Neurochem. 2014;128:818&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">24286619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Zhao W., Zhang M., Wang P., Zhao K., Zhao X., Yang S., Gao C. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J.&#xa0;Virol. 2013;87:4507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624380</ArticleId><ArticleId IdType="pubmed">23388719</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-A., Young M.-J., Wang Y.-C., Chen S.-H., Liu C.-Y., Lo Y.-A., Jen H.-H., Hsu K.-C., Hung J.-J. USP24 promotes drug resistance during cancer therapy. Cell Death Differ. 2021;28:2690&#x2013;2707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408266</ArticleId><ArticleId IdType="pubmed">33846536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Tong X., Ye X. Ndfip1 negatively regulates RIG-I&#x2013;dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J.&#xa0;Immunol. 2012;189:5304&#x2013;5313.</Citation><ArticleIdList><ArticleId IdType="pubmed">23087404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Yu C.K. Animal models of enterovirus 71 infection: applications and limitations. J.&#xa0;Biomed. Sci. 2014;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4013435</ArticleId><ArticleId IdType="pubmed">24742252</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M., Chen Z.J. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell. 2010;141:315&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2919214</ArticleId><ArticleId IdType="pubmed">20403326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Gong F. Involvement of USP24 in the DNA damage response. Mol. Cell Oncol. 2016;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4845166</ArticleId><ArticleId IdType="pubmed">27308530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Li X., Cai X., Zha H., Zhou Z., Sun X., Rong F., Tang J.-W., Zhu C., Liu X., Fan S., Wang J., Liao Q., Ouyang G., Xiao W. Arginine monomethylation by PRMT7 controls MAVS-mediated antiviral innate immunity. Mol. Cell. 2021;81:3171&#x2013;3186.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34171297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Message S.D., Mallia P., Kebadze T., Contoli M., Ward C.K., Barnathan E.S., Mascelli M.A., Kon O.M., Papi A., Stanciu L.A., Edwards M.R., Jeffery P.K., Johnston S.L. Bronchial mucosal IFN0&#xb1;22 and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J.&#xa0;Allergy Clin. Immun. 2019;143:114&#x2013;125.e114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6320262</ArticleId><ArticleId IdType="pubmed">29698627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>